04 February 2019 by Daniel Morales Cano

Effects of HIV-1 and Schistosoma mansoni co-exposure on pulmonary vascular disease

Schistosomiasis and HIV infection are independently associated with pulmonary vascular disease (PVD). HIV patients in some regions of Africa show as high as 60% co-infection with Schistosoma. However, the effects of the co-infection on PVD development are still unknown. We hypothesized that co-exposure may potentiate PVD and results in a different pathological pattern.

Wild-type (WT) and Tg26 transgenic mice expressing HIV-1 proteins (HIV) were intraperitoneally sensitized and intravenously challenged two weeks later with inactivated Schistosoma mansoni eggs. Hemodynamic measurements were recorded in open-chest mice. Quantitative analysis of inflammatory cytokines in lung homogenates were analysed by qRT-PCR. Pulmonary vascular (PV) remodeling and peri-egg granuloma were analysed by immunohistochemistry, and immune cells into the lungs were characterized by flow cytometry.

There was a modest but significant increase in the mean pulmonary arterial pressure following Schsitosoma challenge in HIV compared to WT mice (HIV:13±0.6mmHg versus WT:11±0.5mmHg). Schistosoma eggs induced granuloma was found to be larger in WT than in HIV lungs. However, HIV lungs had a significantly higher egg burden (10.5±1.9eggs/mg), compared to WT (4.6+1.3eggs/mg), suggesting an impairment in egg clearance. Furthermore, HIV mice had more closed pulmonary arterioles than WT mice, which had predominantly hypertrophied muscular layers. In both, WT and HIV mice, exposure to Schistosoma eggs increased interleukin (IL)-4 and IL-13 levels, but not interferon (IFN)-γ or tumor necrosis factor (TNF)-α. Leukocyte counts in the lungs showed a reduction in CD11bhi myeloid cells, B cells and αβ (both CD4+ and CD8+) T cells, but increased γδ T cells in HIV, as compared to WT mice.

HIV and Schistosoma co-exposure resulted in a different remodeling phenotype than either factor alone, suggesting that the dysregulation of inflammatory responses induced by HIV proteins may influence the pattern of PV remodeling. The consequences of these findings on the development of pulmonary disease need further evaluation

About the author

profile picture of Daniel Morales Cano

Daniel Morales Cano


Spanish National Center for Cardiovascular Research


Key Contributors

Morales-Cano D 1, Mondejar-Parreño G 1, Medrano-Garcia S 2, Barreira B 1, Callejo M 1, Esquivel-Ruiz S 1, Kumar R 3, Kosanovic D 4, Mathie A 5, Fernández-Malavé E 2, Graham BB 3, Schermuly RT 4, Moreno L 1, Pérez-Vizcaíno F 1, Cogolludo A 1, Butrous G 5 : 1 Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Enfermedades Respiratorias, Madrid, Spain . 2 Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine and 12 de Octubre Health Research Institute (imas12), Madrid, Spain. 3 Department of Medicine, University of Colorado, Denver, CO, USA. 4 Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Giessen, Germany. 5 Medway School of Pharmacy, University of Kent and University of Greenwich, Chatham, United Kingdom.

Comments (0)

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI